Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Dupixent 200 mg solution for injection in pre-filled syringe
DRUG
2 trials
Sponsors
Centre Hospitalier Universitaire De Nantes
, Regeneron Pharmaceuticals Inc.
Conditions
Atopic Dermatitis
atopic dermatitis
Phase 3
An Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Dupilumab in Patients ≥6 Months to <18 Years of Age With Atopic Dermatitis.
Active, not recruiting
CTIS2023-509425-53-00
Regeneron Pharmaceuticals Inc.
Atopic Dermatitis
Start: 2015-11-09
Target: 201
Updated: 2025-11-04
Phase 4
Dupilumab step-down strategy to maintain remission in adult and adolescents patients with atopic dermatitis: a non-inferiority randomized trial
Active, not recruiting
CTIS2022-501179-23-00
Centre Hospitalier Universitaire De Nantes
atopic dermatitis
Start: 2023-03-08
Target: 256
Updated: 2025-07-11
Related Papers
Dupilumab step-down strategy to maintain remission in adult and adolescent patients with atopic dermatitis: study protocol for a non-inferiority randomized trial (MADULO).
2025-12-05